Filtered By:
Vaccination: Pneomococcal Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1255 results found since Jan 2013.
Patient-reported reactogenicity and safety of COVID-19 vaccinations vs. comparator vaccinations: a comparative observational cohort study
In the course of the SARS-CoV-2 pandemic, multiple vaccines were developed. Little was known about reactogenicity and safety in comparison to established vaccines, e.g. influenza, pneumococcus, or herpes zoste...
Source: BMC Medicine - September 19, 2023 Category: Internal Medicine Authors: Felix Werner, Nikoletta Zeschick, Thomas K ühlein, Philipp Steininger, Klaus Überla, Isabelle Kaiser, Maria Sebastião, Susann Hueber and Lisette Warkentin Tags: Research article Source Type: research
Baseline immune states (BIS) associated with vaccine responsiveness and factors that shape the BIS
Semin Immunol. 2023 Sep 15;70:101842. doi: 10.1016/j.smim.2023.101842. Online ahead of print.ABSTRACTVaccines are among the greatest inventions in medicine, leading to the elimination or control of numerous diseases, including smallpox, polio, measles, rubella, and, most recently, COVID-19. Yet, the effectiveness of vaccines varies among individuals. In fact, while some recipients mount a robust response to vaccination that protects them from the disease, others fail to respond. Multiple clinical and epidemiological factors contribute to this heterogeneity in responsiveness. Systems immunology studies fueled by advances in...
Source: Seminars in Immunology - September 17, 2023 Category: Allergy & Immunology Authors: Djamel Nehar-Belaid Mark Sokolowski Sathyabaarathi Ravichandran Jacques Banchereau Damien Chaussabel Duygu Ucar Source Type: research
The serotype-specific prevalence of pneumococci in hospitalized pneumonia patients with COPD: a prospective, multi-center, cohort study
CONCLUSIONS: Serotypes 22F, 6A, and 6B, which are covered either by PPV 23 or by PCV 13, are still common pneumococcal serotypes in COPD pneumonia in the post-vaccination era in Korea.PMID:37586811 | DOI:10.3904/kjim.2023.152
Source: The Korean Journal of Internal Medicine - August 16, 2023 Category: Internal Medicine Authors: Jae Yeol Kim Jae-Woo Jung Min-Jong Kang Deog Kyeom Kim Hayoung Choi Young-Jae Cho Seung Hun Jang Chang-Hoon Lee Yeon Mok Oh Ji Sook Park Source Type: research
Resolution of Eosinophilic Pneumonia after Coronavirus Disease 2019 without Systemic Corticosteroids
Intern Med. 2023 Aug 16. doi: 10.2169/internalmedicine.1648-23. Online ahead of print.ABSTRACTPulmonary and extrapulmonary complications after coronavirus disease 2019 (COVID-19) have been major public health concerns during the COVID-19 pandemic. Although post-COVID-19 pulmonary manifestations cover a wide spectrum, eosinophilic pneumonia (EP) has rarely been reported. To date, only four cases of EP potentially triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been reported, all of which required systemic corticosteroid therapy. We herein report the first case of post-COVID-19 EP res...
Source: Internal Medicine - August 16, 2023 Category: Internal Medicine Authors: Yumiko Misaki Yusuke Hayashi Masahiro Shirata Kazuhiro Terada Akihiko Yoshizawa Ryo Sakamoto Kohei Ikezoe Kiminobu Tanizawa Tomohiro Handa Toyohiro Hirai Source Type: research
The serotype-specific prevalence of pneumococci in hospitalized pneumonia patients with COPD: a prospective, multi-center, cohort study
CONCLUSIONS: Serotypes 22F, 6A, and 6B, which are covered either by PPV 23 or by PCV 13, are still common pneumococcal serotypes in COPD pneumonia in the post-vaccination era in Korea.PMID:37586811 | DOI:10.3904/kjim.2023.152
Source: The Korean Journal of Internal Medicine - August 16, 2023 Category: Internal Medicine Authors: Jae Yeol Kim Jae-Woo Jung Min-Jong Kang Deog Kyeom Kim Hayoung Choi Young-Jae Cho Seung Hun Jang Chang-Hoon Lee Yeon Mok Oh Ji Sook Park Source Type: research
Resolution of Eosinophilic Pneumonia after Coronavirus Disease 2019 without Systemic Corticosteroids
Intern Med. 2023 Aug 16. doi: 10.2169/internalmedicine.1648-23. Online ahead of print.ABSTRACTPulmonary and extrapulmonary complications after coronavirus disease 2019 (COVID-19) have been major public health concerns during the COVID-19 pandemic. Although post-COVID-19 pulmonary manifestations cover a wide spectrum, eosinophilic pneumonia (EP) has rarely been reported. To date, only four cases of EP potentially triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been reported, all of which required systemic corticosteroid therapy. We herein report the first case of post-COVID-19 EP res...
Source: Internal Medicine - August 16, 2023 Category: Internal Medicine Authors: Yumiko Misaki Yusuke Hayashi Masahiro Shirata Kazuhiro Terada Akihiko Yoshizawa Ryo Sakamoto Kohei Ikezoe Kiminobu Tanizawa Tomohiro Handa Toyohiro Hirai Source Type: research
The serotype-specific prevalence of pneumococci in hospitalized pneumonia patients with COPD: a prospective, multi-center, cohort study
CONCLUSIONS: Serotypes 22F, 6A, and 6B, which are covered either by PPV 23 or by PCV 13, are still common pneumococcal serotypes in COPD pneumonia in the post-vaccination era in Korea.PMID:37586811 | DOI:10.3904/kjim.2023.152
Source: The Korean Journal of Internal Medicine - August 16, 2023 Category: Internal Medicine Authors: Jae Yeol Kim Jae-Woo Jung Min-Jong Kang Deog Kyeom Kim Hayoung Choi Young-Jae Cho Seung Hun Jang Chang-Hoon Lee Yeon Mok Oh Ji Sook Park Source Type: research
Resolution of Eosinophilic Pneumonia after Coronavirus Disease 2019 without Systemic Corticosteroids
Intern Med. 2023 Aug 16. doi: 10.2169/internalmedicine.1648-23. Online ahead of print.ABSTRACTPulmonary and extrapulmonary complications after coronavirus disease 2019 (COVID-19) have been major public health concerns during the COVID-19 pandemic. Although post-COVID-19 pulmonary manifestations cover a wide spectrum, eosinophilic pneumonia (EP) has rarely been reported. To date, only four cases of EP potentially triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been reported, all of which required systemic corticosteroid therapy. We herein report the first case of post-COVID-19 EP res...
Source: Internal Medicine - August 16, 2023 Category: Internal Medicine Authors: Yumiko Misaki Yusuke Hayashi Masahiro Shirata Kazuhiro Terada Akihiko Yoshizawa Ryo Sakamoto Kohei Ikezoe Kiminobu Tanizawa Tomohiro Handa Toyohiro Hirai Source Type: research
Respiratory Infections
Pneumonia is one of the most common reasons for health care utilization in the United States. It can be caused by many different pathogens, but rarely is it able to be identified in specific cases. This has led most racial disparities research to focus on community acquired pneumonia and microbes of public health concern such as influenza, tuberculosis, and COVID-19. Differences have been shown to exist from prevention with vaccines to management and outcomes. COVID-19 has led to a significant increase in the awareness of this topic.
Source: Clinics in Chest Medicine - July 29, 2023 Category: Respiratory Medicine Authors: Joshua F. Detelich, Jordan A. Kempker Source Type: research
